Fulgent Genetics (FLGT) Other Working Capital Changes (2015 - 2026)

Fulgent Genetics has reported Other Working Capital Changes for 6 years, with the latest figure at -$259000.0 in Q2 2026.

• Quarterly Other Working Capital Changes rose 79.94% year-over-year to -$259000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.8 million (down 0.5% YoY) and the FY2025 annual result came in at -$1.6 million, up 56.91% from the prior year.
• Other Working Capital Changes improved to -$259000.0 in Q2 2026 per FLGT's latest filing, from -$627000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $4.8 million in Q2 2022 and troughed at -$5.7 million in Q4 2022.
• A 5-year average of -$673166.7 and a median of -$789500.0 in 2024 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes tumbled 271.19% in 2022, then surged 138.49% in 2025.
• Over 5 years, Other Working Capital Changes stood at -$8.2 million in 2022, then jumped by 81.33% to -$1.5 million in 2023, then jumped by 68.33% to -$483000.0 in 2024, then advanced by 7.66% to -$446000.0 in 2025, then surged by 41.93% to -$259000.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$259000.0, -$627000.0, and -$446000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.